查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2016574

梅毒檢測市場：按類型、地點和地區分類（2026-2034 年）

Syphilis Testing Market by Type (Primary and Secondary Syphilis, Latent and Tertiary Syphilis), Location of Testing (Laboratory Testing, Point-of-Care (POC) Testing), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

2025年全球梅毒檢測市場規模達13.4億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到20.7億美元，2026年至2034年的複合年成長率為4.82% 。性行為感染感染（STI）的流行、流產率的上升以及醫療保健行業對有效疾病診斷和檢測解決方案日益成長的需求是推動該市場發展的主要因素。

梅毒是一種性行為感染感染（STI），通常由性接觸引起，並透過皮膚或黏膜接觸傳播。初期症狀包括生殖器、直腸或口腔出現無痛性潰瘍。如不及時治療，可發展為第三期併發症，損害腦部、神經、血管及關節。快速血漿反應素試驗（RPR）和性病實驗室檢測（VDRL）現已成為醫療專業人員常用的標準檢測方法。這些方法有助於早期發現梅毒，從而進行更恰當的治療，並性行為感染傳染病（STI）的傳播和進展。因此，梅毒檢測在檢查室和即時檢測（PoC）中心被廣泛用於診斷梅毒類型並確定合適的治療方法。

梅毒檢測市場趨勢：

性行為感染(STI) 治療的認知不斷提高，是推動市場成長的主要因素。因此，各國政府和各類非政府組織 (NGO) 正積極進行宣傳活動，提高民眾對性行為感染預防和現有治療方法（包括梅毒）的認知。這促進了快速梅毒試紙等檢測套組的普及，從而推動了市場成長。這些試劑盒可在家中進行準確診斷，幫助人們快速做出決策，進而促進市場成長。此外，這些試劑盒使用方便，價格實惠，且在網路零售商和實體藥局均有銷售，這也是推動市場成長的原因之一。同時，醫學領域的重大進步以及旨在將有效治療方法推向市場的最新研發活動也對市場成長產生了積極影響。最後，有利於性行為感染檢測的醫療報銷政策也促進了市場成長。其他促成市場前景樂觀的因素包括：性行為感染（包括梅毒）的盛行率不斷上升；無保護性行為的發生率不斷增加；有效篩檢方案的廣泛實施；以及對疾病早期診斷的日益重視。

本報告解答的主要問題

  • 全球梅毒檢測市場迄今為止的發展趨勢是什麼？您認為未來幾年它將如何發展？
  • 全球梅毒檢測市場的促進因素、阻礙因素和機會是什麼？
  • 主要區域市場有哪些？
  • 哪個國家的梅毒檢測市場最具吸引力？
  • 按類型分類的市場組成是什麼？
  • 依施行地點，市場區隔如何？
  • 全球梅毒檢測市場的競爭格局如何？
  • 全球梅毒檢測市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球梅毒檢測市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 一期梅毒和二期梅毒
  • 潛伏性梅毒和第三期梅毒

第7章 市場區隔：依施行地點

  • 檢查室檢測
  • 即時偵測 (POC)

第8章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章：促進、抑制與機遇

第10章：價值鏈分析

第11章：波特五力分析

第12章：價格分析

第13章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • DRG International Inc.（BioCheck Inc.）
    • F. Hoffmann-La Roche AG
    • Siemens Healthineers AG（Siemens AG）
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A6876

The global syphilis testing market size reached USD 1.34 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.07 Billion by 2034, exhibiting a growth rate (CAGR) of 4.82% during 2026-2034. The growing prevalence of sexually transmitted diseases (STDs), the increasing incidences of miscarriages, and the rising need for effective disease diagnosing and testing solutions in the healthcare sector represent some of the key factors driving the market.

Syphilis refers to a sexually transmitted infection (STI) that is usually caused by sexual contact and is spread amongst individuals through the skin or mucous membrane contact. It starts as a painless sore on the genitals and rectum of the mouth. If left untreated, it might trigger complications of tertiary syphilis, wherein the disease may damage the brain, nerves, blood vessels, and joints. At present, rapid plasma reagin (RPR) and venereal diseases research laboratory (VDRL) are standard testing practices that are being used by practitioners. These approaches provide early detection for better treatment and mitigate the spread and development of sexually transmitted diseases (STDs). As a result, syphilis testing is frequently used in laboratories and point-of-care (PoC) centers to diagnose the syphilis type and identify its proper treatment.

SYPHILIS TESTING MARKET TRENDS:

The increasing awareness regarding STD treatment represents one of the key factors driving the market growth. In line with this, governments of various nations, along with different non-governmental organizations (NGOs) are actively undertaking campaigns to sensitize the common mass regarding the prevention of STDs, including syphilis, and the available treatment options. This, in turn, is facilitating the adoption of syphilis testing kits, such as syphilis rapid test strips, which is favorably supporting the market growth. These kits offer at-home testing with effective diagnostic results, and thus timely decision-making, which is also contributing to the market growth. Additionally, the convenience of usage and the easy availability of these test kits at online retail stores and in-store pharmacies at affordable price points are contributing to the market growth. Apart from this, the considerable improvements in the healthcare sector and the recent research and development (R&D) activities to launch effective treatment alternatives are positively impacting the market growth. Moreover, the presence of favorable medical reimbursement policies for the testing of sexually transmitted infections is contributing to the market growth. Other factors, such as the increasing prevalence of STDs, including syphilis, rising incidences of unprotected sexual intercourse, the widespread implementation of effective screening programs, and an enhanced focus on the early diagnostic of the disease, are creating a positive outlook for the market.

KEY MARKET SEGMENTATION:

Type Insights:

  • Primary and Secondary Syphilis
  • Latent and Tertiary Syphilis

The report has also provided a detailed breakup and analysis of the syphilis testing market based on the type. This includes primary and secondary, and latent and tertiary syphilis. According to the report, primary and secondary syphilis represented the largest segment.

Location of Testing Insights:

  • Laboratory Testing
  • Point-of-Care (POC) Testing

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for syphilis testing. Some of the factors driving the North America syphilis testing market included the increasing prevalence of STDs, significant technological advancements, and extensive research and development (R&D) activities.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global syphilis testing market. Detailed profiles of all major companies have also been provided. Some of the companies covered includes Abbott Laboratories, Becton Dickinson and Company, Bio-Rad Laboratories Inc., Danaher Corporation, DRG International Inc. (BioCheck Inc.), F. Hoffmann-La Roche AG, Siemens Healthineers AG (Siemens AG), Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global syphilis testing market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global syphilis testing market?
  • What are the key regional markets?
  • Which countries represent the most attractive syphilis testing markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the location of testing?
  • What is the competitive structure of the global syphilis testing market?
  • Who are the key players/companies in the global syphilis testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Syphilis Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Primary and Secondary Syphilis
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Latent and Tertiary Syphilis
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Location of Testing

  • 7.1 Laboratory Testing
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Point-of-Care (POC) Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Becton Dickinson and Company
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Bio-Rad Laboratories Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Danaher Corporation
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 DRG International Inc. (BioCheck Inc.)
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 F. Hoffmann-La Roche AG
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Siemens Healthineers AG (Siemens AG)
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Thermo Fisher Scientific Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Syphilis Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Syphilis Testing Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Syphilis Testing Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Syphilis Testing Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Syphilis Testing Market: Breakup by Location of Testing (in %), 2025
  • Figure 6: Global: Syphilis Testing Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Syphilis Testing (Primary and Secondary Syphilis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Syphilis Testing (Primary and Secondary Syphilis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Syphilis Testing (Latent and Tertiary Syphilis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Syphilis Testing (Latent and Tertiary Syphilis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Syphilis Testing (Laboratory Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Syphilis Testing (Laboratory Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Syphilis Testing (Point-of-Care (POC) Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Syphilis Testing (Point-of-Care (POC) Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: North America: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: North America: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: United States: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: United States: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Canada: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Canada: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Asia-Pacific: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Asia-Pacific: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: China: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: China: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Japan: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Japan: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: India: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: India: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: South Korea: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: South Korea: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Australia: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Australia: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Indonesia: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Indonesia: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Others: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Others: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Europe: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Europe: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Germany: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Germany: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: France: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: France: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: United Kingdom: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: United Kingdom: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Italy: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Italy: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Spain: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Spain: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Russia: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Russia: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Others: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Others: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Latin America: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Latin America: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Brazil: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Brazil: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Mexico: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Mexico: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Others: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Others: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Middle East and Africa: Syphilis Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Middle East and Africa: Syphilis Testing Market: Breakup by Country (in %), 2025
  • Figure 63: Middle East and Africa: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Global: Syphilis Testing Industry: Drivers, Restraints, and Opportunities
  • Figure 65: Global: Syphilis Testing Industry: Value Chain Analysis
  • Figure 66: Global: Syphilis Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Syphilis Testing Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Syphilis Testing Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Syphilis Testing Market Forecast: Breakup by Location of Testing (in Million USD), 2026-2034
  • Table 4: Global: Syphilis Testing Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Syphilis Testing Market: Competitive Structure
  • Table 6: Global: Syphilis Testing Market: Key Players